Search for: [Abstract = "ntraoperative blood loss in the SND group was 485.67 ml \(60\-1500 ml\), median 400.0 \(250\; 630\), in the BML group 469.35 ml \(180\-1300 ml\), median 395 \(292, 5\; 612.5\). There was no statistical difference for blood loss between the two groups, p = 0.853 The mean duration of drainage in the control group was 5.38 days \(1\-16 days\), median 5.0 \(3.0\; 7.0\), in the study group it was 5.97 days \(1\-15 days\), median 6, 0 \(4.8\; 7.0\). There was no statistical difference between the two groups depending on the duration of the drainage, p = 0.173. There was no statistical difference between the two groups depending on the parameters of spirometry and diffusion p = 0.187 Postoperative complications Complications were more frequent in the SND 11 group \(2.5%\) than in the BML 12 group \(24.5%\), but the difference was not statistically significant, p = 0.19. Discussion Surgical treatment is an essential treatment for lung cancer. Standard operations includes excision of a lobe or lung with mediastinal lymph nodes on the operated side. Extended lymphadenectomy is rarely performed and is not a routine procedure. Among the methods of treatment, only a few offer extended mediastinal lymphadenectomy. These include cervical extended mediastinal lymphadenectomy \(TEMLA\), video assisted VAMLA mediastinal lymphadenectomy and bilateral mediastinal lymphadenectomy with cervical approach. VAMLA \(Video\-assi"]

Number of results: 1